跳至主要内容
临床试验/NL-OMON35864
NL-OMON35864已完成不适用

The immunological aspects of conventional therapies for the treatment of cervical cancer. An exploratory study to monitor the immunological effects of radiotherapies in cervical cancer patients - The immunological effects of radiotherapy

eids Universitair Medisch Centrum0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Patients should be at least 18 years of age;
  • - Patients should be able and willing to provide informed consent;
  • - Patients should have the clinical diagnosis of cervical cancer;
  • - Patients are scheduled for:
  • 1. Primary external beam radiotherapy (EBRT) with intra-uterine brachytherapy (BT);
  • 2. Primary EBRT with intra-uterine brachytherapy (BT) and concurrent chemotherapy (Cisplatin);
  • 3. Primary EBRT with intra-uterine brachytherapy (BT) and combined with hyperthermia;
  • 4. Adjuvant, post-operative external beam radiotherapy (EBRT);
  • 5. Adjuvant, post-operative EBRT with concurrent chemotherapy (Cisplatin).

排除标准

  • - Any medical condition that may interfere with the study objectives;
  • - Positive test result for HIV or Hepatitis B;
  • - Any other active malignancy than cervical cancer.

研究者

相似试验